Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()

Detalles Bibliográficos
Autores principales: Tchelebi, Leila T., Goodman, Karyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
COVID-19 Rapid Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357500/
https://www.ncbi.nlm.nih.gov/pubmed/32673775
http://dx.doi.org/10.1016/j.radonc.2020.07.011
_version_ 1783558693271371776
author Tchelebi, Leila T.
Goodman, Karyn
author_facet Tchelebi, Leila T.
Goodman, Karyn
author_sort Tchelebi, Leila T.
collection PubMed
description
format Online
Article
Text
id pubmed-7357500
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73575002020-07-13 Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”() Tchelebi, Leila T. Goodman, Karyn Radiother Oncol COVID-19 Rapid Letter Elsevier B.V. 2021-01 2020-07-13 /pmc/articles/PMC7357500/ /pubmed/32673775 http://dx.doi.org/10.1016/j.radonc.2020.07.011 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle COVID-19 Rapid Letter
Tchelebi, Leila T.
Goodman, Karyn
Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
title Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
title_full Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
title_fullStr Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
title_full_unstemmed Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
title_short Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”()
title_sort response to, “role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of covid-19 and beyond”()
topic COVID-19 Rapid Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357500/
https://www.ncbi.nlm.nih.gov/pubmed/32673775
http://dx.doi.org/10.1016/j.radonc.2020.07.011
work_keys_str_mv AT tchelebileilat responsetoroleofneoadjuvantradiochemotherapyforesophagealcancersoverpreperioperativechemotherapyintheeraofcovid19andbeyond
AT goodmankaryn responsetoroleofneoadjuvantradiochemotherapyforesophagealcancersoverpreperioperativechemotherapyintheeraofcovid19andbeyond

Ejemplares similares